Reassessing immune control of hepatitis A virus

Current Opinion in Virology

Volumn 11, Issue , 2015, Pages 7-13

  Walker, Christopher M ^a,b   Feng, Zongdi ^a,b   Lemon, Stanley M ^c,d  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; BIOGENESIS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMICAL STRUCTURE; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; INNATE IMMUNITY; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS ENTRY; VIRUS IMMUNITY; VIRUS PARTICLE; VIRUS PATHOGENESIS; BLOOD; CD4+ T LYMPHOCYTE; IMMUNOLOGY;

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS A; HEPATITIS A VIRUS; HUMANS; IMMUNITY, INNATE;

EID: 84921476110     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.01.003     Document Type: Review

References (41)

1. Feinstone SM, Kapikian AZ, Purcell RH: Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973, 182:1026-1028.
2. Thimme R, Binder M, Bartenschlager R: Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. FEMS Microbiol Rev 2012, 36:663-683.
3. Wang X, Ren J, Gao Q, Hu Z, Sun Y, Li X, Rowlands DJ, Yin W, Wang J, Stuart DI et al.: Hepatitis A virus and the origins of picornaviruses. Nature 2014 http://dx.doi.org/10.1038/nature13806.
4. Siegl G, Weitz M, Kronauer G: Stability of hepatitis A virus. Intervirology 1984, 22:218-226.
5. Probst C, Jecht M, Gauss-Muller V: Intrinsic signals for the assembly of hepatitis A virus particles. Role of structural proteins VP4 and 2A. J Biol Chem 1999, 274:4527-4531.
6. Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, Jeong SH, Walker C, Lanford RE, Lemon SM: A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature 2013, 496:367-371.
7. Feng Z, Hirai-Yuki A, McKnight KL, Lemon SM: Naked viruses that aren't always naked: quasi-enveloped agents of acute hepatitis. Ann Rev Virol 2014, 1:539-560.
8. Votteler J, Sundquist WI: Virus budding and the ESCRT pathway. Cell Host Microbe 2013, 14:232-241.
9. Colombo M, Raposo G, Thery C: Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 2014, 30:255-289.
10. Boyer JL: Bile formation and secretion. Compr Physiol 2013, 3:1035-1078.
11. Asher LVS, Binn LN, Mensing TL, Marchwicki RH, Vassell RA, Young GD: Pathogenesis of hepatitis A in orally inoculated owl monkeys (Aotus trivergatus). J Med Virol 1995, 47:260-268.
12. Lanford RE, Feng Z, Chavez D, Guerra B, Brasky KM, Zhou Y, Yamane D, Perelson AS, Walker CM, Lemon SM: Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA. Proc Natl Acad Sci U S A 2011, 108:11223-11228.
13. Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon SM: Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A 2007, 104:7253-7258.
14. Qu L, Feng Z, Yamane D, Liang Y, Lanford RE, Li K, Lemon SM: Disruption of TLR3 signaling due to cleavage of TRIF by the hepatitis A virus protease-polymerase processing intermediate, 3CD. PLoS Pathog 2011, 7:e1002169.
15. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ: Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 2005, 102:17717-17722.
16. Wang D, Fang L, Wei D, Zhang H, Luo R, Chen H, Li K, Xiao S: Hepatitis A virus 3C protease cleaves NEMO to impair induction of beta interferon. J Virol 2014, 88:10252-10258.
17. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, Isogawa M, Chisari FV: Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 2010, 107:7431-7436.
18. Guzylack-Piriou L, Bergamin F, Gerber M, McCullough KC, Summerfield A: Plasmacytoid dendritic cell activation by foot-and-mouth disease virus requires immune complexes. Eur J Immunol 2006, 36:1674-1683.
19. Wang JP, Asher DR, Chan M, Kurt-Jones EA, Finberg RW: Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA. J Immunol 2007, 178:3363-3367.
20. Feng Z, Li Y, McKnight KL, Hensley L, Lanford RE, Walker CM, Lemon SM: Human pDCs preferentially sense enveloped hepatitis A virions. J Clin Invest 2014 http://dx.doi.org/10.1172/JCI77527.
21. Dreux M, Garaigorta U, Boyd B, Decembre E, Chung J, Whitten-Bauer C, Wieland S, Chisari FV: Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe 2012, 12:558-570.
22. Lau DT, Negash A, Chen J, Crochet N, Sinha M, Zhang Y, Guedj J, Holder S, Saito T, Lemon SM et al.: Innate immune tolerance and the role of kupffer cells in differential responses to interferon therapy among patients with HCV genotype 1 infection. Gastroenterology 2013, 144:402-413.
23. Yamane D, McGivern DR, Wauthier E, Yi M, Madden VJ: Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nat Med 2014, 20:927-935.
24. Hong S, Lee HW, Chang DY, You S, Kim J, Park JY, Ahn SH, Yong D, Han KH, Yoo OJ et al.: Antibody-secreting cells with a phenotype of Ki-67low, CD138high, CD31high, and CD38high secrete nonspecific IgM during primary hepatitis A virus infection. J Immunol 2013, 191:127-134.
25. Lemon SM, Binn LN: Serum neutralizing antibody response to hepatitis A virus. J Infect Dis 1983, 148:1033-1039.
26. Victor JC, Monto AS, Surdina TY, Suleimenova SZ, Vaughan G, Nainan OV, Favorov MO, Margolis HS, Bell BP: Hepatitis A vaccine versus immune globulin for postexposure prophylaxis. N Engl J Med 2007, 357:1685-1694.
27. Ping LH, Lemon SM: Antigenic structure of human hepatitis A virus defined by analysis of escape mutants selected against murine monoclonal antibodies. J Virol 1992, 66:2208-2216.
28. Lemon SM, Murphy PC, Provost PJ, Chalikonda I, Davide JP, Schofield TL, Nalin DR, Lewis JA: Immunoprecipitation and virus neutralization assays demonstrate qualitative differences between protective antibody responses to inactivated hepatitis A vaccine and passive immunization with immune globulin. J Infect Dis 1997, 176:9-19.
29. Maier K, Gabriel P, Koscielniak E, Stierhof YD, Wiedmann KH, Flehmig B, Vallbracht A: Human gamma interferon production by cytotoxic T lymphocytes sensitized during hepatitis A virus infection. J Virol 1988, 62:3756-3763.
30. Fleischer B, Fleischer S, Maier K, Wiedmann KH, Sacher M, Thaler H, Vallbracht A: Clonal analysis of infiltrating T lymphocytes in liver tissue in viral hepatitis A. Immunology 1990, 69:14-19.
31. Schulte I, Hitziger T, Giugliano S, Timm J, Gold H, Heinemann FM, Khudyakov Y, Strasser M, Konig C, Castermans E et al.: Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infection. J Hepatol 2010, 54:201-208.
32. Zhou Y, Callendret B, Xu D, Brasky KM, Feng Z, Hensley LL, Guedj J, Perelson AS, Lemon SM, Lanford RE et al.: Dominance of the CD4+ T helper cell response during acute resolving hepatitis A virus infection. J Exp Med 2012, 209:1481-1492.
33. Misumi I, Alirezaei M, Eam B, Su MA, Whitton JL, Whitmire JK: Differential T cell responses to residual viral antigen prolong CD4+ T cell contraction following the resolution of infection. J Immunol 2013, 191:5655-5668.
34. Choi YS, Lee J, Lee HW, Chang DY, Sung PS, Jung MK, Park JY, Kim JK, Lee JI, Park H et al.: Liver injury in acute hepatitis A is associated with decreased frequency of regulatory T cells caused by Fas-mediated apoptosis. Gut 2014 http://dx.doi.org/10.1136/gutjnl-2013-306213.
35. Kim HY, Eyheramonho MB, Pichavant M, Gonzalez Cambaceres C, Matangkasombut P, Cervio G, Kuperman S, Moreiro R, Konduru K, Manangeeswaran M et al.: A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest 2011, 121:1111-1118.
36. Manangeeswaran M, Jacques J, Tami C, Konduru K, Amharref N, Perrella O, Casasnovas JM, Umetsu DT, Dekruyff RH, Freeman GJ et al.: Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans. Gastroenterology 2012, 142 1516-25.e3.
37. Kemball CC, Harkins S, Whitmire JK, Flynn CT, Feuer R, Whitton JL: Coxsackievirus B3 inhibits antigen presentation in vivo, exerting a profound and selective effect on the MHC class I pathway. PLoS Pathog 2009, 5:e1000618.
38. Sant AJ, McMichael A: Revealing the role of CD4(+) T cells in viral immunity. J Exp Med 2012, 209:1391-1395.
39. Sjogren MH, Tanno H, Fay O, Sileoni S, Cohen BD, Burke DS, Feighny RJ: Hepatitis A virus in stool during clinical relapse. Ann Intern Med 1987, 106:221-226.
40. Normann A, Jung C, Vallbracht A, Flehmig B: Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients. J Med Virol 2004, 72:10-16.
41. Adams DH, Eksteen B, Curbishley SM: Immunology of the gut and liver: a love/hate relationship. Gut 2008, 57:838-848.